Published in J Biol Chem on January 10, 1975
Vitamin D receptor and coactivators SRC2 and 3 regulate epidermis-specific sphingolipid production and permeability barrier formation. J Invest Dermatol (2008) 1.24
Alterations of neutral glycolipids in cells infected with syncytium-producing mutants of herpes simplex virus type 1. J Virol (1977) 0.91
Thylakoid membrane biogenesis in Chlamydomonas reinhardtii 137+: cell cycle variations in the synthesis and assembly of polar glycerolipid. J Cell Biol (1981) 0.85
Alterations in cell surface glycosphingolipids and other lipid classes of fibroblasts in familial hypercholesterolemia. Proc Natl Acad Sci U S A (1976) 0.83
Long-chain neutral glycolipids and gangliosides of murine fibroblast lines and their low- and high-tumourigenic hybrids. Proc Natl Acad Sci U S A (1976) 0.79
Structure of a lipid intermediate in cell wall peptidoglycan synthesis: a derivative of a C55 isoprenoid alcohol. Proc Natl Acad Sci U S A (1967) 4.15
Detection of blood vessels in retinal images using two-dimensional matched filters. IEEE Trans Med Imaging (1989) 3.76
Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum (2004) 3.46
Herpes simplex encephalitis: a diagnostic and therapeutic reapprisal. J Assoc Physicians India (1993) 2.68
Replication, establishment of latency, and induced reactivation of herpes simplex virus gamma 1 34.5 deletion mutants in rodent models. J Clin Invest (1993) 2.59
Identification of a herpes simplex virus 1 glycoprotein gene within a gene cluster dispensable for growth in cell culture. Proc Natl Acad Sci U S A (1987) 2.48
The biosynthesis of mannosyl-1-phosphoryl-polyisoprenol in Micrococcus lysodeikticus and its role in mannan synthesis. Proc Natl Acad Sci U S A (1968) 2.30
Quantitative determination of the neutral glycosyl ceramides in human blood. J Lipid Res (1967) 2.04
Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol (1998) 1.90
The expression cassette determines the functional activity of ribozymes in mammalian cells by controlling their intracellular localization. RNA (1997) 1.84
Cytoplasmic synthesis of type 5 adenovirus capsid proteins. Proc Natl Acad Sci U S A (1968) 1.81
YMXM motifs of IRS-1 define substrate specificity of the insulin receptor kinase. Proc Natl Acad Sci U S A (1992) 1.79
Sequences near the termini are required for transposition of the maize transposon Ac in transgenic tobacco plants. Proc Natl Acad Sci U S A (1989) 1.71
Synthesis, transport, and morphogenesis of type adenovirus capsid proteins. J Virol (1970) 1.67
Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors. J Virol (1994) 1.63
Inverse relation between Braak stage and cerebrovascular pathology in Alzheimer predominant dementia. J Neurol Neurosurg Psychiatry (1999) 1.63
Biosynthesis of the peptidoglycan of bacterial cell walls. XXI. Isolation of free C55-isoprenoid alcohol and of lipid intermediates in peptidoglycan synthesis from Staphylococcus aureus. J Biol Chem (1970) 1.60
Improved exposure of isolated perimembranous ventricular septal defects. Ann Thorac Surg (2000) 1.59
Mersacidin, a new antibiotic from Bacillus. Fermentation, isolation, purification and chemical characterization. J Antibiot (Tokyo) (1992) 1.58
Integration of adeno-associated virus vectors in CD34+ human hematopoietic progenitor cells after transduction. Blood (1996) 1.57
Unusual type of epidemic conjunctivitis in Ghana. Br J Ophthalmol (1970) 1.56
Cholera toxin production by the El Tor variant of Vibrio cholerae O1 compared to prototype El Tor and classical biotypes. J Clin Microbiol (2010) 1.56
Microsurgical trabeculectomy in Ghana. Br J Ophthalmol (1972) 1.53
Device-associated nosocomial infection rates in intensive care units of seven Indian cities. Findings of the International Nosocomial Infection Control Consortium (INICC). J Hosp Infect (2007) 1.51
Properties of feline leukemia virus. I. Chromatographic separation and analysis of the polypeptides. J Virol (1974) 1.51
Subclinical hypothyroidism: a determinant of polycystic ovary syndrome. Horm Res (1993) 1.49
The identification of trans-2-tetradecenoic acid in hydrolysates of lipid A from Escherichia coli. Biochim Biophys Acta (1972) 1.47
Pharmacologic disruption of base excision repair sensitizes mismatch repair-deficient and -proficient colon cancer cells to methylating agents. Clin Cancer Res (1999) 1.46
Detection of antibodies to herpes simplex virus in the cerebrospinal fluid of patients with herpes simplex encephalitis. J Infect Dis (1987) 1.43
Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma. Proc Natl Acad Sci U S A (1995) 1.41
Low-level secretion of human hepatitis B virus virions caused by two independent, naturally occurring mutations (P5T and L60V) in the capsid protein. J Virol (2000) 1.41
Enzyme replacement in Fabry's disease, an inborn error of metabolism. Science (1970) 1.41
Long-term followup of a randomized trial of 0 versus 3 months of neoadjuvant androgen ablation before radical prostatectomy. J Urol (2003) 1.40
The new genetics and its application in the study of childhood muscular dystrophies. J Assoc Physicians India (1991) 1.39
Analysis of acylcarnitines as their N-demethylated ester derivatives by gas chromatography-chemical ionization mass spectrometry. Anal Biochem (1991) 1.39
Young male with systemic lupus erythematosus presenting with sensorineural deafness with immune suppression induced miliary tuberculosis. J Assoc Physicians India (2011) 1.39
Giant cell tumour of short bones of hand. J Indian Med Assoc (1995) 1.38
Effect of cloned human interferons on protein synthesis and morphogenesis of herpes simplex virus. J Virol (1985) 1.38
Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts. Arthritis Rheum (2001) 1.36
Mass spectrometric determination of unresolved components in gas chromatographic effluents. Anal Chem (1966) 1.36
Characterization of the iso-branched sphinganines from the ceramide phospholipids of Bacteroides melaninogenicus. Biochim Biophys Acta (1969) 1.32
A novel Campylobacter jejuni two-component regulatory system important for temperature-dependent growth and colonization. J Bacteriol (1999) 1.31
Overlapping but distinct RNA elements control repression and activation of nanos translation. Mol Cell (2000) 1.30
Sindbis virus entry into cells triggers apoptosis by activating sphingomyelinase, leading to the release of ceramide. J Virol (2000) 1.29
Glycosphingolipids: structure, biological source, and properties. Methods Enzymol (1989) 1.28
The Marek's disease virus (MDV) unique short region: alphaherpesvirus-homologous, fowlpox virus-homologous, and MDV-specific genes. Virology (1995) 1.26
Correlation of TEM, SHV and CTX-M extended-spectrum beta lactamases among Enterobacteriaceae with their in vitro antimicrobial susceptibility. Indian J Med Microbiol (2011) 1.25
Prophylaxis against malaria. BMJ (1995) 1.25
Structural characterization of oligosaccharides by high-performance liquid chromatography, fast-atom bombardment-mass spectrometry, and exoglycosidase digestion. Anal Biochem (1984) 1.23
Tumor necrosis factor alpha promotes nuclear localization of cytokine-inducible CCAAT/enhancer binding protein isoforms in hepatocytes. J Biol Chem (1996) 1.22
Tumor necrosis factor-alpha stimulates the maturation of sterol regulatory element binding protein-1 in human hepatocytes through the action of neutral sphingomyelinase. J Biol Chem (1998) 1.22
Enzyme therapy in Fabry disease: differential in vivo plasma clearance and metabolic effectiveness of plasma and splenic alpha-galactosidase A isozymes. Proc Natl Acad Sci U S A (1979) 1.21
Levels of antioxidant defenses are decreased in bovine spermatozoa after a cycle of freezing and thawing. Mol Reprod Dev (2000) 1.21
Involvement of NAD-poly(ADP-ribose) metabolism in p53 regulation and its consequences. Cancer Res (1995) 1.20
Genetic analysis of the role of Pol II holoenzyme components in repression by the Cyc8-Tup1 corepressor in yeast. Genetics (2000) 1.20
A rapid screening procedure for the isolation of nonconditional replication mutants of Mason-Pfizer monkey virus: identification of a mutant defective in pol. Virology (1985) 1.19
Cholera toxin (CTX) genetic element in Vibrio cholerae O139. Microbiology (1995) 1.18
Inhibition of SH2 domain/phosphoprotein association by a nonhydrolyzable phosphonopeptide. Biochemistry (1992) 1.18
Immune responses to adeno-associated virus and its recombinant vectors. Gene Ther (2003) 1.18
Glycosphingolipids: structure, biological source, and properties. Methods Enzymol (1978) 1.17
A rhynchosaur from the Upper Triassic Maleri Formation of India. Philos Trans R Soc Lond B Biol Sci (1974) 1.17
Generalized transduction in Rhizobium meliloti. Mol Gen Genet (1980) 1.16
The herpes simplex virus 1 segment inversion site is specifically cleaved by a virus-induced nuclear endonuclease. Proc Natl Acad Sci U S A (1991) 1.15
Triacontanol: a new naturally occurring plant growth regulator. Science (1977) 1.15
Dynamic contrast enhanced magnetic resonance imaging of the breast is superior to triple assessment for the pre-operative detection of multifocal breast cancer. Ann Surg Oncol (1999) 1.13
The modification of deoxyribonucleohistone by trypsin and chymotrypsin. Eur J Biochem (1973) 1.12
Epidermal growth factor receptor induced apoptosis: potentiation by inhibition of Ras signaling. FEBS Lett (2001) 1.12
Platelets in hyperacute rejection of heterotopic cardiac allografts in presensitized dogs. An experimental study. Am J Pathol (1973) 1.10
Evaluation of a test based on baculovirus-expressed glycoprotein G for detection of herpes simplex virus type-specific antibodies. J Infect Dis (1991) 1.10
Chemistry and metabolism of sphingolipids. 3-Oxo derivatives of N-acetylsphingosine and N-acetyldihydrosphingosine. J Am Chem Soc (1966) 1.10
Her-2/neu expression in prostate cancer: high level of expression associated with exposure to hormone therapy and androgen independent disease. J Urol (2001) 1.10
Nanostructure and strain in InGaN/GaN superlattices grown in GaN nanowires. Nanotechnology (2013) 1.09
Marek's disease herpesviruses. IV. Molecular characterization of Marek's disease herpesvirus A antigen. J Virol (1983) 1.09
Studies on herpes simplex virus type 1 glycoproteins using monoclonal antibodies. Virology (1986) 1.08
Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade. Br J Ophthalmol (2004) 1.07
Interferon inhibits Sendai virus-induced cell fusion: an effect on cell membrane fluidity. Proc Natl Acad Sci U S A (1982) 1.07
Pilot scale purification of alpha-galactosidase A from Cohn fraction IV-1 of human plasma. Biochim Biophys Acta (1978) 1.07
The gas5 gene is disrupted by a frameshift mutation within its longest open reading frame in several inbred mouse strains and maps to murine chromosome 1. Mamm Genome (1998) 1.06
Redox-regulated signaling by lactosylceramide in the proliferation of human aortic smooth muscle cells. J Biol Chem (1997) 1.06
Lactosylceramide mediates tumor necrosis factor-alpha-induced intercellular adhesion molecule-1 (ICAM-1) expression and the adhesion of neutrophil in human umbilical vein endothelial cells. J Biol Chem (1998) 1.06
Folding pathway mediated by an intramolecular chaperone. Proc Natl Acad Sci U S A (1993) 1.05
Properties of feline leukemia virus. II. In vitro labeling of the polypeptides. J Virol (1974) 1.05
Balhimycin, a new glycopeptide antibiotic produced by Amycolatopsis sp. Y-86,21022. Taxonomy, production, isolation and biological activity. J Antibiot (Tokyo) (1994) 1.05
Detection and characterization of metallo beta lactamases producing Pseudomonas aeruginosa. Indian J Med Microbiol (2010) 1.04
Structural studies of urinary oligosaccharides from patients with mannosidosis. Arch Biochem Biophys (1981) 1.03
A method for the quantitative determination of neutral glycosphingolipids in urine sediment. J Lipid Res (1970) 1.03
Growth control of human foreskin fibroblasts and inhibition of extracellular sialidase activity by 2-deoxy-2,3-dehydro-N-acetylneuraminic acid. J Biol Chem (1988) 1.03
Extensive homology exists between Marek disease herpesvirus and its vaccine virus, herpesvirus of turkeys. Proc Natl Acad Sci U S A (1984) 1.03
Properties of feline leukemia virus. III. Analysis of the RNA. J Virol (1975) 1.03
Glycolipid and mucopolysaccharide abnormality in fibroblasts of fabry's disease. Science (1969) 1.03
A rare presentation of oral pemphigus vulgaris as multiple pustules. Kathmandu Univ Med J (KUMJ) (2008) 1.03
Effect of monensin on Mason-Pfizer monkey virus glycoprotein synthesis. J Virol (1982) 1.02
Marek's Disease Herpesviruses II. Purification and Further Characterization of Marek's Disease Herpesvirus A Antigen. J Virol (1975) 1.02
Concentrations of glycosyl ceramides in plasma and red cells in Fabry's disease, a glycolipid lipidosis. J Lipid Res (1969) 1.02
Novel dipeptide aldehydes are proteasome inhibitors and block the MHC-I antigen-processing pathway. J Immunol (1995) 1.02
Marek's Disease Herpesviruses I. Production and Preliminary Characterization of Marek's Disease Herpesvirus A Antigen. J Virol (1975) 1.02
Selective induction of apoptosis through activation of caspase-8 in human leukemia cells (Jurkat) by dandelion root extract. J Ethnopharmacol (2010) 1.02
Analysis of trimethylsilyl O-methyloximes of carbohydrates by combined gas-liquid chromatography-mass spectrometry. Anal Biochem (1971) 1.01